An interventional study of easyEndoTM Lite linear cutting stapler and loading units in Thoracic Surgery, sponsored by Ezisurg Medical Co. Ltd.. Completed at 1 site in China. Per ClinicalTrials.gov, last updated 2026-01-15.
Sponsored by Ezisurg Medical Co. Ltd. · Not applicable, Interventional, and Treatment
A retrospective, single-arm, observation study to Evaluate the clinical safety and performance of Ezisurg stapler in thoracic surgery, 900 patients using the easyEndoTM Lite linear cutting stapler and loading units during thoracic surgery from 2021.03-2022.12 in Fujian Medical University Union Hospital. The surgical decision was made by the surgeons, and no other specification restrictions.
Ezisurg Medical Co. Ltd. is the lead sponsor of 7 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
The study population were patients using the easyEndoTM Lite linear cutting stapler and loading units during thoracic surgery from 2021.03-2022.12 in Fujian Medical University Union Hospital. The surgical decision was made by the surgeons, and no other specification restrictions.
Device: easyEndoTM Lite linear cutting stapler and loading units
using the easyEndoTM Lite linear cutting stapler and loading units during thoracic surgery
stapling success rate
No intrate-operative and post-operative air-leak
Time frame: Perioperative/Periprocedural
Intraoperative blood loss
Time frame: Perioperative/Periprocedural
Rate of convert to open surgery
Time frame: Perioperative/Periprocedural
Hospitalization time
Time frame: Perioperative/Periprocedural
Incidence of postoperative complications
Time frame: Perioperative/Periprocedural
Readmission rate
Time frame: 30 days
This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ezisurg Medical Co. Ltd.